4.7 Article

Detection and characterization of latency stage of EBV and histopathological analysis of prostatic adenocarcinoma tissues

Related references

Note: Only part of the references are listed.
Review Oncology

Estimating the global burden of Epstein-Barr virus-related cancers

Yide Wong et al.

Summary: More than 90% of the adult population globally is chronically infected by the Epstein-Barr virus (EBV), which is associated with various malignancies. This review focuses on six cancers with a relatively large EBV-related case burden and estimates the new cases and deaths in 2020. The findings highlight the significant global impact of EBV-related cancers and suggest potential for EBV-specific therapeutic interventions.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)

Article Microbiology

Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection

Tomoki Inagaki et al.

Summary: The study reveals that during Epstein-Barr virus infection, cell growth is reprogrammed and a burst of viral lytic gene expression occurs in the early stage of infection. Infectious virions are not produced in the pre-latent phase, indicating an abortive lytic infection, which ultimately converges to latent infection. The BZLF1 protein, a key regulator of reactivation, is found to be dispensable for abortive lytic infection in the pre-latent phase, suggesting divergent regulation of viral gene expressions from productive lytic infection.

FRONTIERS IN MICROBIOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Virology

Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation

Takayuki Murata et al.

Summary: Epstein-Barr virus (EBV) is a causative agent of infectious mononucleosis and several types of cancer, establishing a lifelong latent infection. Reactivation involves various regulatory mechanisms, in addition to just progeny production.

VIRUSES-BASEL (2021)

Review Oncology

Roles of Inflammasomes in Epstein-Barr Virus-Associated Nasopharyngeal Cancer

Chin King Looi et al.

Summary: Epstein-Barr virus (EBV) infection triggers nasopharyngeal carcinoma (NPC) by activating inflammasomes to induce the production of pro-inflammatory cytokines, but abnormal activation of inflammasomes may lead to chronic inflammation promoting carcinogenesis. Further studies are needed to explore the precise roles and mechanisms of inflammasomes in EBV-associated NPC and the potential of targeting inflammasomes for NPC treatment.

CANCERS (2021)

Article Oncology

Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer

Javid Sadri Nahand et al.

Summary: The study evaluated the potential role of HPV and EBV coinfection in prostate cancer development. The findings suggest that HPV/EBV coinfection may influence tumor development and progression through modulation of cellular behaviors.

BMC CANCER (2021)

Article Microbiology

EBV latent membrane proteins promote hybrid epithelial-mesenchymal and extreme mesenchymal states of nasopharyngeal carcinoma cells for tumorigenicity

Nannan Zhu et al.

Summary: The coordinated action of EBV membrane proteins LMP1 and LMP2A generates various intermediate subpopulations in the EMT spectrum in nasopharyngeal carcinoma, which are responsible for distinct tumorigenic features such as tumor initiation, vasculogenesis, and metastasis.

PLOS PATHOGENS (2021)

Review Oncology

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma

Pok Man Hau et al.

FRONTIERS IN ONCOLOGY (2020)

Article Oncology

Epstein-Barr virus-associated gastric cancer: A distinct subtype

Jing Yang et al.

CANCER LETTERS (2020)

Review Oncology

Epstein Barr Virus Associated Lymphomas and Epithelia Cancers in Humans

Richmond Ayee et al.

JOURNAL OF CANCER (2020)

Article Oncology

Microbiome signatures in prostate cancer

Sagarika Banerjee et al.

CARCINOGENESIS (2019)

Review Oncology

Outlooks on Epstein-Barr virus associated gastric cancer

Madiha Naseem et al.

CANCER TREATMENT REVIEWS (2018)

Review Surgery

Viral etiology of prostate cancer: Genetic alterations and immune response. A literature review

Syed Hani Abidi et al.

INTERNATIONAL JOURNAL OF SURGERY (2018)

Article Pathology

Gleason grade grouping of prostate cancer is of prognostic value in Asian men

Joe Yeong et al.

JOURNAL OF CLINICAL PATHOLOGY (2017)

Review Biology

Epstein-Barr virus infection and nasopharyngeal carcinoma

Sai Wah Tsao et al.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)

Article Multidisciplinary Sciences

Identification of Pathogen Signatures in Prostate Cancer Using RNA-seq

Yunqin Chen et al.

PLOS ONE (2015)

Article Multidisciplinary Sciences

AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome

Markus Kalla et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Oncology

No link between viral findings in the prostate and subsequent cancer development

J. Bergh et al.

BRITISH JOURNAL OF CANCER (2007)